Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Ozempic
Ozempic
Page 6 of 9
Newsletters
CEO Sima Sistani didn’t think running WeightWatchers would be this hard
By
Emma Hinchliffe
and
Joey Abrams
June 11, 2024
Health
Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the viral drugs are in stock
By
Marco Quiroz-Gutierrez
May 29, 2024
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential longevity pills
By
Jessica Firger
May 26, 2024
Health
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By
Lindsey Leake
May 22, 2024
Retail
Nestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
By
Sasha Rogelberg
May 21, 2024
Conferences
Hims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
By
Marco Quiroz-Gutierrez
May 21, 2024
Retail
Bernie Sanders urges Danish pharma giant Novo Nordisk to lower its drug prices: ‘Help the American people’
By
Christian Wienberg
and
Bloomberg
May 13, 2024
Health
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By
Ashleigh Furlong
and
Bloomberg
May 12, 2024
Retail
People will keep eating Oreos despite Ozempic surge, according to CEO of maker, Mondelez
By
Deena Shanker
and
Bloomberg
May 3, 2024
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By
Naomi Kresge
and
Bloomberg
May 2, 2024
Health
No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said
By
Jonel Aleccia
and
The Associated Press
April 13, 2024
Success
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By
Ryan Hogg
April 10, 2024
Health
The saga of ‘Ozempig’: Minor league baseball team ripped for fat-shaming with insensitive mascot name
By
Scott McFettridge
and
The Associated Press
March 29, 2024
Politics
‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture
By
Madison Muller
,
Robert Langreth
and
Bloomberg
March 28, 2024
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By
Madison Muller
,
Robert Langreth
and
Bloomberg
March 28, 2024
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents show
By
Sasha Rogelberg
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartest
By
Nick Lichtenberg
Economy
Gen Z’s straight‑A boom is quietly shrinking their paychecks
By
Jake Angelo